From: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
RSV-positive patients per study site (N, range)
Total RSV-positive patients (N)
Total RSV-related deaths (N)
Group A
30–120
840
84
Group B
10–30
60
6
Total
NA
900
90